Literature DB >> 23338485

Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.

Ming Wang1, Chenglong Li, Beiqin Yu, Liping Su, Jianfang Li, Jingfang Ju, Yingyan Yu, Qinlong Gu, Zhenggang Zhu, Bingya Liu.   

Abstract

BACKGROUND: MicroRNAs can promote or suppress the evolution of malignant behaviors by regulating multiple targets. We aimed to determine the expression of miR-301a recently screened in gastric cancer, to investigate the biological effects of miR-301a and to identify the specific miR-301a target gene.
METHODS: Quantitative real-time RT-PCR was used to test miR-301a expression. Functional effects were explored by a water-soluble tetrazolium salt assay, a colony formation assay in soft agar, a migration assay, an invasion assay and cytometry used to determine apoptosis and cell cycle. Nude mice were inoculated subcutaneously by retrovirus-mediated stably expressed SGC-7901 cells. The target gene was determined by bioinformatic algorithms, dual luciferase reporter assay and Western blot.
RESULTS: Firstly, we found that miR-301a was significantly upregulated both in cells and tissues of gastric cancer. The expression level of miR-301a was inversely correlated with tumor differentiation of gastric cancer tissues. Secondly, miR-301a promoted cell growth, soft agar clonogenicity, migration, invasion, and decreased cell apoptosis induced by cisplatin in vitro, while blockage of miR-301a reduced the percentage of G2/M phase cells via flow cytometry in gastric cancer cells. Ectopic expression of miR-301a enhanced the subcutaneous tumorigenesis in vivo. Finally, miR-301a directly downregulated RUNX3 expression post-transcriptionally in gastric cancer.
CONCLUSION: Our results demonstrate that miR-301a plays important roles in the development of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23338485     DOI: 10.1007/s00535-012-0733-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

1.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.

Authors:  W Yasui; H Yokozaki; J Fujimoto; K Naka; H Kuniyasu; E Tahara
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

5.  Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1.

Authors:  Yu Chen; Xufeng Wei; Changcun Guo; Haifeng Jin; Zheyi Han; Ying Han; Taidong Qiao; Kaichun Wu; Daiming Fan
Journal:  Int J Cancer       Date:  2011-06-21       Impact factor: 7.396

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

8.  In vitro differentiation of Runx3-/- p53-/- gastric epithelial cells into intestinal type cells.

Authors:  Hiroshi Fukamachi; Ayako Mimata; Issei Tanaka; Kosei Ito; Yoshiaki Ito; Yasuhito Yuasa
Journal:  Cancer Sci       Date:  2008-04       Impact factor: 6.716

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  42 in total

1.  Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer.

Authors:  Min Zhao; Jingchun Sun; Zhongming Zhao
Journal:  Mol Biosyst       Date:  2013-10-16

Review 2.  The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses.

Authors:  Xiaoyun Ding; Xiangxiang Wan; Haizhong Jiang; Haojun Song; Ying Fang; Shengcan Chen; Peifei Li; Junming Guo
Journal:  Tumour Biol       Date:  2015-06

Review 3.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 4.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

5.  Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer.

Authors:  Hong Yu; Hui Li; Hua Qian; Xia Jiao; Xiaowei Zhu; Xiaoqin Jiang; Guihong Dai; Junxing Huang
Journal:  Med Oncol       Date:  2014-10-14       Impact factor: 3.064

6.  MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.

Authors:  Bo Liang; Jun-Jie Yin; Xin-Rong Zhan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 7.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

8.  Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop.

Authors:  Xiang Xia; Shuchang Wang; Bo Ni; Shunpeng Xing; Hui Cao; Zizhen Zhang; Fengrong Yu; Enhao Zhao; Gang Zhao
Journal:  Oncogene       Date:  2020-08-21       Impact factor: 9.867

9.  Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer.

Authors:  Fuminori Sonohara; Yoshikuni Inokawa; Masamichi Hayashi; Yasuhiro Kodera; Shuji Nomoto
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

10.  MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.

Authors:  Gillian Browne; Julie A Dragon; Deli Hong; Terri L Messier; Jonathan A R Gordon; Nicholas H Farina; Joseph R Boyd; Jennifer J VanOudenhove; Andrew W Perez; Sayyed K Zaidi; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Tumour Biol       Date:  2016-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.